The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Development of novel antiangiogenic compounds for colorectal cancer using a tumor explant model and zebrafish.
A. G. Murphy
No relevant relationships to disclose
D. W. Fennelly
No relevant relationships to disclose
A. Reynolds
No relevant relationships to disclose
M. Tosetto
No relevant relationships to disclose
J. Hyland
No relevant relationships to disclose
K. Sheahan
No relevant relationships to disclose
D. O'Donoghue
No relevant relationships to disclose
H. Mulcahy
No relevant relationships to disclose
B. Kennedy
No relevant relationships to disclose
J. O'Sullivan
No relevant relationships to disclose